Vinva Investment Management Ltd Has $3.79 Million Position in Zoetis Inc. (NYSE:ZTS)

Vinva Investment Management Ltd lifted its stake in shares of Zoetis Inc. (NYSE:ZTS) by 8.2% during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 19,456 shares of the company’s stock after acquiring an additional 1,467 shares during the period. Vinva Investment Management Ltd’s holdings in Zoetis were worth $3,790,000 at the end of the most recent reporting period.

Other institutional investors also recently modified their holdings of the company. Cetera Investment Advisers lifted its position in shares of Zoetis by 275.2% during the 1st quarter. Cetera Investment Advisers now owns 96,085 shares of the company’s stock valued at $16,259,000 after acquiring an additional 70,476 shares during the period. Simplify Asset Management Inc. bought a new stake in Zoetis during the 3rd quarter valued at $11,684,000. Soltis Investment Advisors LLC bought a new stake in Zoetis during the 1st quarter valued at $688,000. Bank Pictet & Cie Asia Ltd. increased its stake in Zoetis by 41.0% during the 2nd quarter. Bank Pictet & Cie Asia Ltd. now owns 37,500 shares of the company’s stock valued at $6,501,000 after purchasing an additional 10,900 shares in the last quarter. Finally, Swedbank AB increased its stake in Zoetis by 56.2% during the 2nd quarter. Swedbank AB now owns 1,946,277 shares of the company’s stock valued at $337,407,000 after purchasing an additional 700,398 shares in the last quarter. Institutional investors and hedge funds own 92.80% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages have commented on ZTS. Argus upgraded shares of Zoetis to a “strong-buy” rating in a research note on Friday, August 9th. Piper Sandler boosted their price target on shares of Zoetis from $195.00 to $210.00 and gave the company an “overweight” rating in a research note on Wednesday, August 14th. Stifel Nicolaus boosted their price target on shares of Zoetis from $200.00 to $210.00 and gave the company a “buy” rating in a research note on Wednesday, September 18th. JPMorgan Chase & Co. boosted their price target on shares of Zoetis from $225.00 to $230.00 and gave the company an “overweight” rating in a research note on Friday, October 11th. Finally, BTIG Research upped their target price on shares of Zoetis from $220.00 to $225.00 and gave the stock a “buy” rating in a research note on Monday, August 12th. Ten investment analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Buy” and an average price target of $221.44.

Zoetis Stock Performance

NYSE ZTS opened at $176.74 on Friday. Zoetis Inc. has a 1 year low of $144.80 and a 1 year high of $201.92. The company has a debt-to-equity ratio of 1.26, a current ratio of 3.69 and a quick ratio of 2.27. The firm has a market cap of $79.74 billion, a price-to-earnings ratio of 33.22, a PEG ratio of 2.71 and a beta of 0.90. The company has a fifty day moving average price of $184.18 and a 200-day moving average price of $180.78.

Zoetis (NYSE:ZTS) last posted its quarterly earnings results on Monday, November 4th. The company reported $1.58 earnings per share for the quarter, beating the consensus estimate of $1.46 by $0.12. The company had revenue of $2.40 billion during the quarter, compared to analyst estimates of $2.29 billion. Zoetis had a net margin of 26.55% and a return on equity of 51.98%. The firm’s revenue for the quarter was up 11.6% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.36 earnings per share. As a group, equities research analysts predict that Zoetis Inc. will post 5.9 EPS for the current fiscal year.

Zoetis Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 3rd. Investors of record on Thursday, October 31st will be given a dividend of $0.432 per share. The ex-dividend date is Thursday, October 31st. This represents a $1.73 annualized dividend and a yield of 0.98%. Zoetis’s payout ratio is currently 32.52%.

Zoetis Company Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.